+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Implants Market - Global Forecast 2026-2032- Product Image
Biological Implants Market - Global Forecast 2026-2032- Product Image
Sale

Biological Implants Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011394
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Implants Market is projected to reach USD 10.13 Billion in 2026. It is expected to continue growing at a CAGR of 6.06%, reaching USD 14.46 Billion by 2032.

Biological implants are moving from conventional tissue repair products toward clinically integrated, biologically responsive solutions used across orthopedics, dentistry, cardiovascular care, ophthalmology, wound reconstruction, and soft-tissue repair. Demand is supported by durable healthcare fundamentals: the World Health Organization reports that musculoskeletal conditions affect about 1.71 billion people worldwide, oral diseases affect roughly 3.5 billion people, and cardiovascular disease remains the leading global cause of death. These disease burdens create sustained need for implants that restore function, accelerate healing, and reduce repeat interventions.

The biological implants market includes allografts, xenografts, demineralized bone matrices, collagen-based scaffolds, acellular dermal matrices, bioresorbable materials, and tissue-engineered constructs. Competitive advantage is increasingly shaped by clinical evidence, donor-tissue traceability, sterilization validation, biocompatibility, reimbursement alignment, and surgeon confidence. As hospitals prioritize measurable outcomes, suppliers that combine biologic performance with regulatory discipline and scalable manufacturing are best positioned for growth.

Transformative Shifts in the Biological Implants Landscape

The biological implants landscape is being reshaped by demographic pressure, regulatory modernization, and a shift toward regenerative and minimally invasive care. Aging populations are increasing the incidence of degenerative joint disease, dental bone loss, cardiovascular valve deterioration, chronic wounds, and ophthalmic disorders. At the same time, value-based care models are encouraging the use of implants that can reduce complications, shorten recovery, and improve long-term functional outcomes.

Technology shifts are also changing product development. Additive manufacturing, decellularization methods, bioactive coatings, advanced sterilization, and controlled-resorption biomaterials are enabling implants that better match anatomy and healing biology. However, stronger scrutiny under frameworks such as U.S. FDA human cells, tissues, and cellular and tissue-based products rules and the European Union Medical Device Regulation is raising expectations for safety, post-market surveillance, and clinical documentation.

Cumulative Impact of Artificial Intelligence on Biological Implants

Artificial intelligence is creating cumulative value across the biological implants lifecycle rather than acting as a single-point disruption. In research and development, AI-enabled image analysis and computational modeling help evaluate anatomical fit, predict mechanical behavior, and screen biomaterial combinations. In clinical planning, machine learning supports segmentation of CT, MRI, dental cone-beam CT, and other imaging data to improve implant selection and surgical precision.

AI also strengthens manufacturing and quality systems by improving defect detection, batch monitoring, and traceability analytics. For biological implants, where tissue variability and sterility assurance are critical, AI-supported process control can help identify deviations earlier and support consistent product performance. Adoption must remain governed by validated datasets, transparent clinical claims, cybersecurity controls, and regulatory expectations for software used in medical decision-making.

Key Regional Insights: Asia-Pacific, North America, Latin America, Europe, Middle East & Africa

North America remains a leading biological implants region due to advanced surgical volumes, high adoption of orthopedic and dental biologics, strong transplant and tissue-bank infrastructure, and established FDA pathways for medical devices, biologics, and HCT/Ps. The United States anchors innovation through specialized hospitals, academic research centers, and commercial-scale suppliers, while Canada contributes through publicly funded care pathways and strong clinical governance.

Europe is shaped by mature healthcare systems, surgeon-led evidence generation, and the compliance demands of EU MDR, which has increased the importance of clinical evaluation, post-market clinical follow-up, and supply-chain documentation. Asia-Pacific is expanding quickly as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems invest in specialty surgery, dental care, trauma management, and local manufacturing. Latin America, led by Brazil and Mexico, shows rising access to advanced reconstruction and dental procedures, although reimbursement and public-private disparities influence uptake. The Middle East, particularly GCC healthcare hubs, is investing in premium hospitals, specialty surgical centers, and medical tourism, while Africa presents long-term potential as surgical capacity, tissue banking, trauma care, and specialist training gradually improve.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7 & NATO

ASEAN demand is supported by expanding private hospitals, medical tourism in markets such as Thailand, Malaysia, and Singapore, and rising access to dental and orthopedic procedures. The GCC is accelerating adoption through high-acuity hospital investment, national health transformation programs, and demand for premium reconstructive technologies. The European Union remains a regulatory bellwether, where MDR compliance, notified body capacity, traceability, and clinical evidence quality strongly affect market access.

BRICS markets offer scale through large patient populations, expanding middle-class access, and government interest in domestic medical technology production, although procurement systems and regulatory maturity vary significantly. G7 countries continue to shape global standards because they combine advanced research ecosystems, high surgical volumes, established reimbursement systems, and stringent quality requirements. NATO countries, while not a healthcare trade bloc, overlap with many high-income markets where resilient medical supply chains, emergency preparedness, trauma readiness, and secure sourcing of critical implants have gained strategic importance.

Key Country Insights Across Major Biological Implants Markets

The United States leads in innovation, procedure volumes, and commercialization of advanced biologics, with FDA oversight and reimbursement evidence driving adoption. Canada favors clinically validated products within cost-sensitive provincial systems, while Mexico benefits from private healthcare growth and cross-border dental and orthopedic care. Brazil is Latin America’s strongest demand center, supported by a large specialist base, established dental care activity, and expanding private hospitals.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show steady demand for orthopedic, dental, ophthalmic, and soft-tissue reconstruction implants, with Germany and France particularly influential in clinical standards, hospital procurement, and medtech manufacturing. Russia’s market is shaped by localization priorities, domestic sourcing initiatives, and procurement constraints. In Asia-Pacific, China and India offer high-volume growth supported by hospital expansion, trauma and orthopedic care needs, and domestic manufacturing, Japan and South Korea emphasize quality, advanced surgery, and aging-related demand, and Australia combines high regulatory standards with strong adoption of evidence-based implant technologies.

Actionable Recommendations for Biological Implant Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, including comparative outcomes, complication reduction, healing performance, and real-world registry data. Regulatory strategy should be integrated early into product development, especially for combination products, tissue-derived materials, and bioactive implants that may face complex classification and documentation requirements.

Manufacturers should strengthen tissue sourcing ethics, donor screening, sterilization validation, cold-chain or controlled-environment logistics, and post-market surveillance. Commercial teams should align surgeon education with payer-relevant value propositions, while R&D teams should invest in bioresorbable scaffolds, antimicrobial surfaces, patient-specific design, and AI-enabled quality systems. Partnerships with hospitals, tissue banks, academic centers, and regional distributors can improve both clinical credibility and market access.

Research Methodology

This executive summary is based on a structured secondary-research approach that synthesizes publicly available evidence from regulatory authorities, public health organizations, peer-reviewed medical literature, clinical practice guidelines, healthcare policy sources, and standards bodies. Core reference points include frameworks from the U.S. FDA, European Commission, national health agencies, the World Health Organization, and recognized clinical and quality organizations.

The analysis evaluates disease burden, demographic indicators, implant categories, technology adoption, regional access patterns, regulatory requirements, reimbursement considerations, and competitive positioning. Insights were cross-checked for consistency across multiple source types and framed to support strategic decision-making for manufacturers, investors, healthcare providers, and market-entry teams in the biological implants ecosystem.

Conclusion

Biological implants are becoming a central component of modern regenerative and reconstructive medicine. Growth is supported by aging populations, chronic disease burden, dental and orthopedic demand, cardiovascular care needs, trauma reconstruction, wound management, and the clinical shift toward products that support natural healing while restoring durable function.

The next phase of competition will be defined by evidence depth, regulatory readiness, manufacturing consistency, ethical tissue sourcing, and intelligent integration of AI across design, planning, and quality assurance. Companies that combine biologic innovation with credible outcomes and region-specific commercialization strategies will be positioned to lead in an environment where safety, trust, and measurable patient benefit are decisive.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biological Implants Market, by Type
7.1. Introduction
7.2. Autografts
7.3. Allografts
7.4. Xenografts
8. Biological Implants Market, by Material
8.1. Introduction
8.2. Collagen-based
8.3. Polymeric Materials
8.4. Tissue-derived
8.5. Hybrid/Bio-composite
9. Biological Implants Market, by Source
9.1. Introduction
9.2. Human-derived
9.3. Animal-derived
9.4. Synthetic-Biological Hybrid
10. Biological Implants Market, by Processing Type
10.1. Introduction
10.2. Decellularization
10.3. Sterilization
10.3.1. Gamma Irradiation
10.3.2. Ethylene Oxide
10.4. Freeze-Drying
10.5. Chemical Treatment
11. Biological Implants Market, by Application
11.1. Introduction
11.2. Orthopedic Implants
11.3. Dental Implants
11.4. Cardiovascular Implants
11.5. Wound Care Implants
11.6. Soft Tissue Implants
11.7. Ophthalmic Implants
11.7.1. Corneal Implants
11.7.2. Ocular Surface Grafts
12. Biological Implants Market, by End User
12.1. Introduction
12.2. Hospitals
12.2.1. Public
12.2.2. Private
12.3. Ambulatory Surgical Centers
12.4. Specialty Clinics
12.5. Research & Academic Institutes
13. Biological Implants Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Biological Implants Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Biological Implants Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. aap Implantate AG
17.2. Abbott Laboratories
17.3. AlloSource
17.4. Arthrex, Inc.
17.5. B. Braun Melsungen AG
17.6. BioHorizons IPH, Inc.
17.7. Bioventus LLC
17.8. Boston Scientific Corporation
17.9. Cerapedics Inc.
17.10. Cochlear Limited
17.11. CollPlant Biotechnologies Ltd.
17.12. Dentsply Sirona Inc.
17.13. Exactech, Inc.
17.14. Globus Medical, Inc.
17.15. Integra LifeSciences Holdings Corporation
17.16. Johnson & Johnson Services, Inc.
17.17. Medtronic plc
17.18. MegaGen Implant Co., Ltd.
17.19. MiMedx Group, Inc.
17.20. NuVasive, Inc.
17.21. Organogenesis Holdings Inc.
17.22. Orthofix Medical Inc.
17.23. Osstem Implant Co., Ltd.
17.24. RTI Surgical Holdings, Inc.
17.25. Smith & Nephew plc
17.26. Straumann Holding AG
17.27. Stryker Corporation
17.28. Tissue Regenix Group plc
17.29. Vericel Corporation
17.30. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL BIOLOGICAL IMPLANTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOLOGICAL IMPLANTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOLOGICAL IMPLANTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL AUTOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL AUTOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL AUTOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL XENOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL XENOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL XENOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL COLLAGEN-BASED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL COLLAGEN-BASED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL COLLAGEN-BASED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL POLYMERIC MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL POLYMERIC MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL POLYMERIC MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL TISSUE-DERIVED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL TISSUE-DERIVED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TISSUE-DERIVED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL HYBRID/BIO-COMPOSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HYBRID/BIO-COMPOSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HYBRID/BIO-COMPOSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN-DERIVED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN-DERIVED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN-DERIVED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ANIMAL-DERIVED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ANIMAL-DERIVED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL-DERIVED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC-BIOLOGICAL HYBRID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC-BIOLOGICAL HYBRID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC-BIOLOGICAL HYBRID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DECELLULARIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DECELLULARIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DECELLULARIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL STERILIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL STERILIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL STERILIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL GAMMA IRRADIATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL GAMMA IRRADIATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL GAMMA IRRADIATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL ETHYLENE OXIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL ETHYLENE OXIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ETHYLENE OXIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL FREEZE-DRYING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL FREEZE-DRYING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FREEZE-DRYING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CHEMICAL TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CHEMICAL TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CHEMICAL TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL WOUND CARE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL WOUND CARE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL WOUND CARE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SOFT TISSUE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SOFT TISSUE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SOFT TISSUE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OPHTHALMIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CORNEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OCULAR SURFACE GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OCULAR SURFACE GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OCULAR SURFACE GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 110. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 112. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 113. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 114. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 115. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 116. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 117. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 118. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 119. EUROPE BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 140. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 142. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 143. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 144. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 145. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 146. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 148. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 153. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 154. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 161. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 163. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 164. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 165. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 166. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 167. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 169. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. NATO BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 171. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 173. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 174. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 175. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 176. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 177. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 178. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 179. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 180. G7 BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 181. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 183. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 184. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 185. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 186. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 187. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 189. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. BRICS BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 201. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 203. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 204. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 205. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 206. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 207. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 209. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. ASEAN BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 211. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 212. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 213. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 214. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 215. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 216. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 217. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 219. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 220. GCC BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 221. GLOBAL BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 222. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 224. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 225. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 226. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 227. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 228. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 230. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 235. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 236. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 237. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 238. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 240. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 241. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 242. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 244. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 245. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 246. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 247. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 248. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 249. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 250. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 252. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 254. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 255. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 256. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 257. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 258. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 260. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 261. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 262. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 264. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 265. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 266. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 267. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 268. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 270. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 271. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 275. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 276. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 277. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 278. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 279. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 280. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 282. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 284. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 285. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 286. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 287. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 288. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 290. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 292. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 294. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 295. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 296. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 297. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 298. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 300. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 301. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 302. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 304. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 305. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 306. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 307. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 308. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 309. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 310. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 311. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 312. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 314. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 315. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 316. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 317. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 318. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 319. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 320. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 322. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 324. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 325. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 326. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 327. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 328. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 329. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 330. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 332. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 333. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 334. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 335. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 336. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 337. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 338. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 339. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 340. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 341. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 345. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 348. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 349. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 350. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 351. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 352. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 353. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 354. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 355. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 356. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 357. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 358. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 359. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 360. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 361. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 362. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 363. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 364. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MATERIAL, 2017-2032 (USD MILLION)
TABLE 365. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 366. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PROCESSING TYPE, 2017-2032 (USD MILLION)
TABLE 367. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY STERILIZATION, 2017-2032 (USD MILLION)
TABLE 368. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 369. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY OPHTHALMIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 370. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 371. S

Companies Mentioned

  • aap Implantate AG
  • Abbott Laboratories
  • AlloSource
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioHorizons IPH, Inc.
  • Bioventus LLC
  • Boston Scientific Corporation
  • Cerapedics Inc.
  • Cochlear Limited
  • CollPlant Biotechnologies Ltd.
  • Dentsply Sirona Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • MegaGen Implant Co., Ltd.
  • MiMedx Group, Inc.
  • NuVasive, Inc.
  • Organogenesis Holdings Inc.
  • Orthofix Medical Inc.
  • Osstem Implant Co., Ltd.
  • RTI Surgical Holdings, Inc.
  • Smith & Nephew plc
  • Straumann Holding AG
  • Stryker Corporation
  • Tissue Regenix Group plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.13 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.46 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Synthetic Bio-implants Market - Global Forecast 2026-2032 - Product Image

Synthetic Bio-implants Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Bio-implant Market - Global Forecast 2026-2032 - Product Image

Bio-implant Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Biological Implants Market - Global Strategic Business Report - Product Image

Biological Implants Market - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Biological Implants Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 182 Pages
  • Global
From
Bio-Implants Market Report 2026 - Product Image

Bio-Implants Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.